spacer
The Healthcare Sales & Marketing Network celebrates 27 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  acromegaly 

 HSMN NewsFeed - 12 Jan 2022
DALI Medical's SAN(R)Light Passive Safety Needle coupled with a novel Drug Product, Enabling User-friendly Administration
Devices Drug Delivery Product Launch
 HSMN NewsFeed - 7 Nov 2019
CASI Pharmaceuticals Enters Exclusive China Distribution License Agreement for Octreotide Long Acting Injectable (LAI) Microsphere for Neuroendocrine Cancers and Acromegaly
Biopharmaceuticals Oncology Licensing Distribution
 HSMN NewsFeed - 30 Jan 2018
FDA Grants Orphan Drug Designation to Dauntless Pharmaceuticals' DP1038 for the Treatment of Acromegaly
Biopharmaceuticals FDA
 HSMN NewsFeed - 5 Dec 2016
Novelion Therapeutics Subsidiary, Aegerion Pharmaceuticals, Enters Into Licensing Agreement With Amryt Pharma for LOJUXTA(R) (lomitapide)
Biopharmaceuticals Cardiology Licensing
 HSMN NewsFeed - 24 Aug 2015
Chiasma Appoints William H. Ludlam, M.D., Ph.D., as Vice President of Medical Affairs
Biopharmaceuticals Endocrinology Personnel
 HSMN NewsFeed - 10 Aug 2015
Chiasma Expands Management Team with Announcement of Anand Varadan as Chief Commercial Officer
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 15 May 2015
Cortendo AB: Cortendo Adds Two Late-Stage Assets to Its Rare Endocrine Disease Franchise and Announces Related $33.2 Million Financing
Biopharmaceuticals Acquisitions Licensing Venture Capital
 HSMN NewsFeed - 16 Mar 2015
Chiasma Announces Mark Leuchtenberger as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 27 Feb 2015
Chiasma Announces Completion of $70 Million Series E Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 16 Dec 2014
Novartis gains FDA approval for Signifor(R) LAR to treat patients with acromegaly, a rare and life-threatening hormonal disorder
Biopharmaceuticals FDA
 HSMN NewsFeed - 1 Jul 2014
Ipsen submits marketing authorization applications in the US and Europe for Somatuline(R) (lanreotide) in the treatment of gastroenteropancreatic neuroendocrine tumors (GEP-NETs)
Biopharmaceuticals Oncology
 HSMN NewsFeed - 14 Jan 2014
Ipsen to set up its own US oncology team for Somatuline(R) Depot(R) (lanreotide) Injection in neuroendocrine tumors
Biopharmaceuticals Oncology
 HSMN NewsFeed - 18 Feb 2013
Roche and Chiasma Announce Collaboration to Develop and Commercialize Chiasma's Octreolin(R) for Acromegaly and Neuroendocrine Tumors
Biopharmaceuticals Endocrinology Licensing
 HSMN NewsFeed - 22 Sep 2010
Novartis Drug SOM230 is First Medical Therapy to Show Efficacy in a Phase III Trial in Cushing's Disease, a Debilitating Hormonal Disorder
Biopharmaceuticals
 HSMN NewsFeed - 26 Aug 2010
World's Tallest Man Stretches Out Over Eight Feet for Needed Gamma Knife Surgery
Devices Oncology
 HSMN NewsFeed - 12 Mar 2009
FDA Accepts Complete Response Submission to New Drug Application for NEBIDO(R)
Biopharmaceuticals FDA
 HSMN NewsFeed - 5 Jan 2009
Indevus Pharmaceuticals Announces Definitive Merger Agreement With Endo Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 26 Sep 2008
Indevus Announces Agreement With Teva to Develop Pagoclone for the Treatment of Stuttering
Biopharmaceuticals Licensing
 HSMN NewsFeed - 27 Aug 2008
Gleevec Receives FDA Priority Review as First Therapy to Reduce Recurrence of Gastrointestinal Stromal Tumors After Surgery
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 30 Jun 2008
Indevus Receives Approvable Letter from FDA for NEBIDO(R)
Biopharmaceuticals FDA
 HSMN NewsFeed - 16 Jun 2008
Tercica Announces Results from Increlex(R) IGFD Patient Registry and Other Increlex(R) Studies at the 90th Meeting of the Endocrine Society
Biopharmaceuticals
 HSMN NewsFeed - 12 Jun 2008
Indevus Announces Management Changes
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Jun 2008
Indevus Pharmaceuticals Provides Update on NEBIDO(R) NDA Status
Biopharmaceuticals FDA
 HSMN NewsFeed - 22 May 2008
Indevus Pharmaceuticals Licenses Canadian Rights for SANCTURA XR(TM) to Allergan, Inc.
Biopharmaceuticals Licensing Urology
 HSMN NewsFeed - 3 Mar 2008
Indevus Pharmaceuticals Announces Retirement Plans For Its CEO and Chairman
Biopharmaceuticals Personnel
 HSMN NewsFeed - 22 Jan 2008
Indevus Reports Additional Positive Phase III Trial Data for NEBIDO(R)
Biopharmaceuticals
 HSMN NewsFeed - 1 Nov 2007
FDA Accepts New Drug Application for NEBIDO(R) Submitted by Indevus
Biopharmaceuticals Endocrinology FDA
 HSMN NewsFeed - 31 Aug 2007
Ipsen: Somatuline(R) Depot Receives Marketing Approval in the United States for the Treatment of Acromegaly
Biopharmaceuticals Endocrinology FDA
 HSMN NewsFeed - 30 Aug 2007
Somatuline(R) Depot Receives FDA Marketing Approval for the Treatment of Acromegaly
Biopharmaceuticals FDA
 HSMN NewsFeed - 9 Aug 2007
Paladin And Glide Pharma Sign Exclusive Agreement for Novel Needle-Free Drug Delivery System
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 16 Jan 2007
Tercica Reports Somatuline(R) Autogel(R) NDA for Acromegaly Accepted for Filing by FDA
Biopharmaceuticals FDA
 HSMN NewsFeed - 15 Jan 2007
FDA Accepts for Filing a New Drug Application (NDA) for Somatuline(R) Autogel(R)
Biopharmaceuticals
 HSMN NewsFeed - 12 Dec 2006
Indevus Pharmaceuticals to Acquire Valera Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 15 Nov 2006
Ambrilia Announces European Licensing Partnership with TEVA for its Lead Oncology Product, Octreotide
Biopharmaceuticals Licensing
 HSMN NewsFeed - 2 Nov 2006
Tercica Reports Somatuline(R) Autogel(R) NDA for Acromegaly Submitted to FDA
Biopharmaceuticals
 HSMN NewsFeed - 19 Oct 2006
Gleevec(R) Approved in the US for Five Rare Life-Threatening Disorders With Limited Treatment Options
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 16 Oct 2006
Ipsen and Tercica Complete Worldwide Strategic Collaboration Agreement in Endocrinology
Biopharmaceuticals Endocrinology Licensing
Return to NewsFeed  

 Additional items found! 14

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 14 additional stories matching:
acromegaly
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.